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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A401Fig 1. Histological Grading of the IFP and SYN (Mean þ/- SD). Bar ¼
statistical difference from group comparison. * ¼ Single IA administration
of DEX signiﬁcantly lowered the histological grade in direct comparison
between Drill and DrillþDEX.
Fig 2. Cartilage Histology (Mean þ/- SD). Bar ¼ statistical difference from
group comparison. * ¼ Single IA administration of DEX signiﬁcantly
lowered the histological grade in direct comparison between Drill and
DrillþDEX.
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INJECTION OF EXTRACELLULAR MATRIX GEL FOLLOWING ANTERIOR
CRUCIATE LIGAMENT INJURY MITIGATES OSTEOARTHRITIC CHANGES
IN A RAT MODEL
B.L. Proffen y, J.T. Sieker y, M.M. Murray y, K.E. Chin z, T.K. Patel z,
E. Robbins z, M.R. Akelman z, J.T. Machan x, B.C. Fleming z. yBoston
Children's Hosp., Harvard Med. Sch., Boston, MA, USA; zWarren Alpert
Med. Sch. of Brown Univ./Rhode Island Hosp., Providence, RI, USA;
xRhode Island Hosp., Providence, RI, USA
Purpose: To investigate whether the development of post-traumatic
osteoarthritis (PTOA) is prevented or modulated in a rat model of
anterior cruciate ligament (ACL) injury following a single intraarticular
injection of an extracellular matrix (ECM) gel/autologous whole blood
composite at day 0 or 14 after ACL injury.
Methods: ECM gels were prepared according to good-laboratory-
practice guidelines from bovine source ECM. Thirty-two Lewis rats
underwent unilateral ACL transection and either subsequent intra-
articular injection of ECM gel/autologouswhole blood composite on day
0 (n¼11 rats, INJ0 group) or day 14 (n¼11 rats, INJ14 group) or nofurther treatment (n¼10, ACLT group), while ten additional animals
received capsulotomy but no ACL transection (n¼10, SHAM group).
Before and 35 days after surgery gait analysis was performed using a
pressure sensing walkway, followed by euthanasia and the assessment
of PTOA-related phenotypes in cartilage, subchondral bone and synovial
tissue. Speciﬁcally, histological scoring was performed according to the
recommendations of the OARSI histopathology initiative, while the
subchondral bone-mineral density was assessed using micro-computed
tomography (micro-CT). The ratio of intact contralateral/treated hind
limb maximum applied forces, was calculated for the pre-surgery and 5
weeks post-surgery timepoints. Then the difference of the pre and post-
surgery ratios were compared between the groups. Further the differ-
ences of intact contralateral and treated tibial subchondral bone-min-
eral density (mg hydroxyappatit/cm^3), as well as the tibial OARSI
histological scores of the treated knees were compared between the
groups using a one-way analysis of variance with post-hoc Bonferroni
test for normally distributed and Kruskal Wallis test with Dunn post-
hoc test for non-normally distributed data. Adjusted p values < 0.05
were considered statistically signiﬁcant.
Results:Weight bearing on the operated limb was decreased by 15% in
the ACLT group ﬁve weeks after surgery (P<0.05), while rats in INJ0 and
INJ14 groups had only non-signiﬁcant 3% and 10% decrease from their
preoperative baseline values, respectively (P¼0.44 and 0.18). All groups
that have received ACLT regardless of the consecutive treatment dem-
onstrated a loss of bone mineral density, with a loss of 99.7 mg/cm^3
(95% CI 81.4, 117.9; P<0.001) in the ACLT, 115.1 mg/cm^3 (95% CI 85.1,
145.0; P<0.001) in the INJ0, and 93.8 (95% CI 72.3, 115.3; P<0.001) in the
INJ14 group, which was signiﬁcant in the comparison to the SHAM
group, that did not demonstrate a loss of bone-mineral density (-4.6mg/
cm^3; 95% CI -21.4, 12.3). In the histological assessment, the cartilage
degeneration sum score was statistically signiﬁcantly worse in the ACLT
group (7.5, 95% CI 7.0, 8.0) than in the SHAM (5.0, 95% CI 4.0, 6.0, P<
0.001), INJ0 (6.1, 95% CI 5.3; 6.9, P¼0.031), and INJ14 group (6.0, 95% CI
5.3, 6.7; P¼0.022), while the difference of INJ0 and INJ14 from SHAM
was not considered statistically signiﬁcant (P¼ 0.161 and 0.276,
respectively). In the histological assessment of the synovium, no sig-
niﬁcant differences between the ACLT (2.6, 95% CI 2.0, 3.2) and the INJ0
(2.5, 95% CI 1.7, 3.4; P¼1.0) or the INJ14 (3.1, 95% CI 2.7, 3.5; P¼0.957)
groups were detected in the histological synovial inﬂammation score,
which were all signiﬁcantly worse (all P<0.001) than SHAM (0.9, 95% CI
0.4, 1.4).
Conclusions: Injection of ECM gel/autologous whole blood composite
reduced damage of cartilage surface after ACL transection, and resulted
in fewer changes in gait asymmetry. However, the treatment did not
prevent subchondral bone-mineral-loss or synovial inﬂammation. Early
or delayed injection of ECM gel/autologous whole blood composite
modulates the development of PTOA after ACL transection in a rat
model, particularly in regards to the cartilage surface and joint function.
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EARLY INTRAARTICULAR TRIAMCINOLONE ACETONIDE
ADMINISTRATION ALTERS ANTERIOR CRUCIATE LIGAMENT INJURY-
INDUCED CHANGES IN SYNOVIAL MEMBRANE GENE EXPRESSION
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yBoston Children's Hosp., Harvard Med. Sch., Boston, MA, USA; zWarren
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Purpose: First, to deﬁne early alterations in gene expression (genes and
pathways) within synovial membranes of a porcine post-traumatic
osteoarthritis [PTOA] model. Second, to assess the efﬁcacy of intra-
articular triamcinolone acetonide to attenuate the synovial membrane’s
response to the surgical anterior cruciate ligament [ACL] injury.
Methods: Eighteen minipigs (meanweight of 33.4 kg) were allocated to
unilateral ACL transection [ACLT] alone, unilateral ACLT and immediate
injection of 20mg triamcinolone acetonide, or no surgery (n ¼ 6 each
group). At 14 days after ACLT, synovial membranes were harvested and
used for RNA-sequencing (RNA-seq) to quantify transcriptome wide
gene expression changes. Raw reads were mapped to the pig genome
(Susscr3, released Aug. 2011) with the RNA-seq uniﬁed mapper (RUM)
pipeline. Reads uniquely aligned to the exons of each gene were
counted with a custom R script that utilizes Rsamtools and Genomics-
Features packages, and used for differential expression analysis with the
edgeR package. P-values were then corrected using a Benjamini &
Hochberg approach to adjust for multiple hypothesis testing to adjust
for the transcriptome-wide analysis. A ﬁlter was applied to exclude very
